First Vbloc Therapy Complete!
We are pleased to announce that first Vbloc gastric inhibitor for weight loss was recently completed as a new component of the bariatric surgery program at Winthrop University Hospital. This is the first such case performed at Winthrop, and we are only the 3rd institution in the US to place the device since the FDA approved it in January 2015. Our patient is the 4th patient in the country to receive the device since FDA approval.
Vbloc therapy is a novel, minimally invasive approach to weight loss. By stimulating the vagal nerve, a small pacemaker-type device can help regulate hunger pangs throughout the day. Significant weight loss and co-morbidity improvement has been noted in patients who have undergone the surgery. As with other bariatric procedures, Vbloc therapy requires that certain qualification criteria be met before the surgery can be performed.
Dr. Brathwaite and the entire bariatric team would like to thank everyone who played an integral role in helping to make this important milestone come to pass.
In addition, a major television network will be running a special on Vbloc therapy, highlighting our program and this particular patient. Please stay tuned to learn more about the air date.